Found: 5
Select item for more details and to access through your institution.
Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation.
- Published in:
- Cell Transplantation, 2021, v. 30, p. 1, doi. 10.1177/09636897211001774
- By:
- Publication type:
- Article
Evaluating the Prognostic Value of Islet Autoantibody Monitoring in Islet Transplant Recipients with Long-Standing Type 1 Diabetes Mellitus.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 12, p. 2708, doi. 10.3390/jcm10122708
- By:
- Publication type:
- Article
En bloc liver and pancreas transplantation after total pancreatectomy with autologous islet transplantation.
- Published in:
- European Journal of Translational & Clinical Medicine, 2020, v. 3, n. 2, p. 11, doi. 10.31373/ejtcm/130187
- By:
- Publication type:
- Article
168-OR: Five-Year Follow-up after Islet Transplantation in Nonuremic Patients with Type 1 Diabetes Mellitus and Hypoglycemia Unawareness: Favorable Long-Term Outcomes of Multicenter Trial at University of Chicago.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-168-OR
- By:
- Publication type:
- Article
1146-P: Persistent Graft Function after Islet Allotransplantation Into Prevascularized Sernova Cell Pouch Device: Preliminary Results from the University of Chicago.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1146-P
- By:
- Publication type:
- Article